These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8541229)

  • 21. Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    Pituitary; 2014 Jun; 17(3):203-9. PubMed ID: 23649927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm.
    Devin-Leclerc J; Meng X; Delahaye F; Leclerc P; Baulieu EE; Catelli MG
    Mol Endocrinol; 1998 Jun; 12(6):842-54. PubMed ID: 9626660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
    Bianco NR; Perry G; Smith MA; Templeton DJ; Montano MM
    Mol Endocrinol; 2003 Jul; 17(7):1344-55. PubMed ID: 12714703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells.
    Speirs V; Kerin MJ; Newton CJ; Walton DS; Green AR; Desai SB; Atkin SL
    Int J Oncol; 1999 Dec; 15(6):1251-4. PubMed ID: 10568836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estradiol prevents amyloid-beta peptide-induced cell death in a cholinergic cell line via modulation of a classical estrogen receptor.
    Marin R; Guerra B; Hernández-Jiménez JG; Kang XL; Fraser JD; López FJ; Alonso R
    Neuroscience; 2003; 121(4):917-26. PubMed ID: 14580942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and beta.
    Tremblay A; Tremblay GB; Labrie C; Labrie F; Giguère V
    Endocrinology; 1998 Jan; 139(1):111-8. PubMed ID: 9421405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G; Katzenellenbogen BS
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prolonged hydroxytamoxifen treatment of MCF-7 cells on mitogen activated kinase cascade.
    Rabenoelina F; Semlali A; Duchesne MJ; Freiss G; Pons M; Badia E
    Int J Cancer; 2002 Apr; 98(5):698-706. PubMed ID: 11920638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell line.
    Ercoli A; Scambia G; Fattorossi A; Raspaglio G; Battaglia A; Cicchillitti L; Malorni W; Rainaldi G; Benedetti Panici P; Mancuso S
    Int J Cancer; 1998 Mar; 76(1):47-54. PubMed ID: 9533761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
    Gaddy VT; Barrett JT; Delk JN; Kallab AM; Porter AG; Schoenlein PV
    Clin Cancer Res; 2004 Aug; 10(15):5215-25. PubMed ID: 15297425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.
    Sirbasku DA; Moreno-Cuevas JE
    In Vitro Cell Dev Biol Anim; 2000; 36(7):428-46. PubMed ID: 11039494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
    Thompson EW; Katz D; Shima TB; Wakeling AE; Lippman ME; Dickson RB
    Cancer Res; 1989 Dec; 49(24 Pt 1):6929-34. PubMed ID: 2582435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative regulation of N-cadherin-mediated cell-cell adhesion by the estrogen receptor signaling pathway in rat pituitary GH3 cells.
    Heinrich CA; Lail-Trecker MR; Peluso JJ; White BA
    Endocrine; 1999 Feb; 10(1):67-76. PubMed ID: 10403573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen mitogenic action. III. is phenol red a "red herring"?
    Moreno-Cuevas JE; Sirbasku DA
    In Vitro Cell Dev Biol Anim; 2000; 36(7):447-64. PubMed ID: 11039495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant.
    Planas-Silva MD; Waltz PK; Kilker RL
    J Steroid Biochem Mol Biol; 2006 Mar; 98(4-5):193-8. PubMed ID: 16464573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between estrogen receptor and Pit-1 protein is influenced by estrogen in pituitary cells.
    Ying C; Lin DH; Sarkar DK; Chen TT
    J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):145-52. PubMed ID: 10369412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.
    Zhou JH; Yu DV; Cheng J; Shapiro DJ
    Steroids; 2007 Oct; 72(11-12):765-77. PubMed ID: 17714751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouse.
    Martel C; Labrie C; Bélanger A; Gauthier S; Mérand Y; Li X; Provencher L; Candas B; Labrie F
    Endocrinology; 1998 May; 139(5):2486-92. PubMed ID: 9564862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells.
    El Khissiin A; Journé F; Laïos I; Seo HS; Leclercq G
    Steroids; 2000 Dec; 65(12):903-13. PubMed ID: 11077089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol inhibited GH3 cell growth and decreased prolactin level via estrogen receptors.
    Wang C; Hu ZQ; Chu M; Wang Z; Zhang WG; Wang LZ; Li CG; Wang JS
    Clin Neurol Neurosurg; 2012 Apr; 114(3):241-8. PubMed ID: 22104698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.